On February 12, 2025, the Foreign Investors Council (FIC) of Serbia elected a new leadership team. Dr. Ronalnd Seeliger, CEO of Hemofarm, was appointed President for the next three years.
Dr. Ana Govedarica, General Manager of Roche Serbia, and Goran Pekez, JTI’s Director of Corporate Affairs for the Adriatic region, were elected Vice Presidents.
FIC Serbia’s mission remains clear: to foster a transparent, competitive, and sustainable business environment, supporting regulatory reforms for economic growth.
As Serbia intensifies EU membership talks, aligning local regulations with European standards and reducing geopolitical investment risks are top priorities.
The focus will also include improving supply chain management, accelerating digitalization, advancing the green transition, and boosting energy independence.
With over 120 global companies contributing over €45 billion in investments and employing more than 116,000 people in Serbia, FIC continues to be a pivotal partner in driving Serbia’s economic modernization.
The new leadership reflects FIC’s commitment to building a stronger, more competitive Serbia.
